Breathing new life into respiratory medicine? Report of the 2004 BTS Winter Meeting

Thorax

Volumn 60, Issue 3, 2005, Pages 183-186

  Powrie, D J ^a   Hurst, J R ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BLEOMYCIN; CEFTAZIDIME; GENTAMICIN; KI 67 ANTIGEN; SIMVASTATIN; TALC; TETRACYCLINE; TOBRAMYCIN; TRIAMCINOLONE;

ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; ASTHMA; BREATHING MUSCLE; BRONCHOSCOPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DRUG INDICATION; EXERCISE TOLERANCE; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH SERVICE; HEALTH STATUS; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; HYPOXIA; INTENSIVE CARE; INTERSTITIAL LUNG DISEASE; LUNG CANCER; LUNG DISEASE; LUNG INFECTION; LUNG NON SMALL CELL CANCER; LUNG TRANSPLANTATION; MEDICAL PRACTICE; MEDICAL SOCIETY; MORTALITY; MUSCLE STRENGTH; NEUTROPHIL; PATHOPHYSIOLOGY; PLEURA BIOPSY; PLEURA DISEASE; PNEUMONIA; POSITIVE END EXPIRATORY PRESSURE; POSTGRADUATE EDUCATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP; SLEEP APNEA SYNDROME; THORACOSCOPY; PULMONOLOGY; RESPIRATORY TRACT DISEASE; UNITED KINGDOM;

HUMANS; LONDON; PULMONARY DISEASE (SPECIALTY); RESPIRATORY TRACT DISEASES;

EID: 14944369418     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.040584     Document Type: Conference Paper

References (72)

1. Jones-Perrott S, Crutchley J, Rowley J. Do comfort visits reduce hospital readmissions in patients with chronic obstructive pulmonary disease (COPD)? A pilot study. Thorax 2004;59(Suppl II):P16.
2. O'Kelly N, Boldy D, Young K. Reduction of hospital admissions with an integrated COPD programme in East Lincolnshire. Thorax 2004;59(Suppl II):P17.
3. Khan A, Barnett M, Dixon N, et al. Effectiveness of an outreach COPD team in reducing hospital admissions. Thorax 2004;59(Suppl II):P19.
4. Wilkinson TMA, Hurst JR, Perera WR, et al. Consequences of respiratory syncytial virus infection in patients with stable COPD. Thorax 2004;59(Suppl II):T6.
5. McManus TE, Marley AM, Baxter NB, et al. Latent viral infection: a possible role in the pathogenesis of COPD. Thorax 2004;59(Suppl II):P50.
6. Hurst JR, Donaldson GC, Wilkinson TMA, et al. Symptom and peak flow changes during the common cold and at exacerbation in patients with COPD. Thorax 2004;59(Suppl II):P14.
7. Garrod R, Marshall J. Respiratory muscle weakness and peripheral muscle weakness in submaximal and maximal exercise in patients with COPD. Thorax 2004;59(Suppl II):S1.
8. Rees D, Graves J, Ayres J, et al. Mid-upper arm circumference provides a good indicator of body mass index in patients with COPD. Thorax 2004;59(Suppl II):S3.
9. Weekes CE, Botemon NT, Elia M, et al. Tailored dietary advice and food fortification results in weight gain and clinical benefit in malnourished patients with chronic obstructive pulmonary disease. Thorax 2004;59(Suppl II):S5.
10. Moore CA, Emmett L, Jones A, et al. Prolonged pulmonary rehabilitation may lead to greater improvement in exercise capacity and health related quality of life. Thorax 2004;59(Suppl II):S88.
11. Griffin J, Tabberer M. COPD death: facing the problem. Thorax 2004;59(Suppl II):S43.
12. Hopkinson NS, Toma TP, Honsell DM, et al. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Thorax 2004;59(Suppl II):S40.
13. Wildman MJ, Groves J, Reeves B, et al. Outcome prediction for admissions with COPD to UK critical care units from CAOS: the COPD and Asthma Outcome Study. Thorax 2004;59(Suppl II):S39.
14. Wildman MJ, Groves J, Reeves B, et al. Health related quality of life and future treatment preferences of patients with COPD admitted to UK critical care units from CAOS: the COPD and Asthma Outcome Study. Thorax 2004;59(Suppl II):S38.
15. Sulaiman MI, Chakrabarti B, Warburton CJ, et al. A study of patient attitudes towards non-invasive ventilatory support and relation to health status in COPD. Thorax 2004;59(Suppl II):S97.
16. White P, Elkington H, Addington-Hall J, et al. Palliative care needs of COPD patients in the last year of life. Thorax 2004;59(Suppl II):S42.
17. Young H, Hoyle S, Butler S, et al. Oxygen concentrators: are they correctly prescribed and when are they cost effective? Thorax 2004;59(Suppl II):P67.
18. Harrison BDW. An ongoing confidential enquiry into asthma deaths in patients aged <65 years. Thorax 2004;59(Suppl II):S16.
19. Shaw DE, Berry MA, Brightling CE, et al. Reducing asthma exacerbations in practise: an observational study. Thorax 2004;59(Suppl II):S100.
20. Berry MA, Shaw DE, Brightling CE, et al. Elevated membrane bound TNFα on peripheral blood monocytes of adults with refractory asthma. Thorax 2004;59(Suppl II):S7.
21. Shaw DE, Murphy A, Berry MA, et al. In approach to the identification and management of poor treatment concordance in potentially life threatening asthma. Thorax 2004;59(Suppl II):S101.
22. Tomlinson JEM, McMahon AD, Chaudhuri R, et al. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2004;59(Suppl II):S27.
23. Jani M, Ogston S, Mukhopadhyay S. Annual increase in body mass index in children with asthma on inhaled steroids. Thorax 2004;59(Suppl II):S32.
24. Saglani S, Payne DNR, Nicholson AG, et al. Thickening of the epithelial reticular basement membrane in preschool children with troublesome wheeze. Thorax 2004;59(Suppl II):S60.
25. Wark PAB, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. Thorax 2004;59(Suppl II):S49.
26. Wark PAB, Bucchieri F, Hamilton LM, et al. Inflammatory mediators release from asthmatic and non-asthmatic bronchial epithelial cells following infection with rhinovirus. Thorax 2004;59(Suppl II):S50.
27. Lee DKC. Unified airway genetics. Thorax 2004;59(Suppl II):P86.
28. Lee DKC. Corticosteroid therapy in the unified airway. Thorax 2004;59(Suppl II):P92.
29. Dickinson J, Whyte G, McConnell A, et al. EVH: a useful challenge for diagnosing EIA in Olympic athletes. Thorax 2004;59(Suppl II):P26.
30. Hallsworth MP, Major PJ, Barnes NC. Where next in clinical asthma research? An innovative approach to research prioritisation. Thorax 2004;59(Suppl II):S102.
31. Marshall MJ, Coughlin SR. Does positive airway pressure therapy (PAP) provide a symptomatic benefit at low levels of compliance in obstructive sleep apnoea patients? Thorax 2004;59(Suppl II):S44.
32. Moylan JG, Marshall MJ. Are the recent changes in the DVLA D4 medical form sufficient to increase detection of obstructive sleep apnoea in a high risk driving population. Thorax 2004;59(Suppl II):P106.
33. Bourke SC, Tomlinson M, Williams TL, et al. Randomised controlled trial of non-invasive ventilation in motor neurone disease. Thorax 2004;59(Suppl II):S94.
34. Tuggey JM, Sundar R, McDonald W, et al. Role of clinical, physiological, and radiological scores in predicting change in patients with idiopathic pulmonary fibrosis and sarcoidosis. Thorax 2004;59(Suppl II):S120.
35. Goh NSL, Sato H, du Bois RM, et al. Serum KL-6 levels are predictive of outcome in patients with idiopathic pulmonary fibrosis. Thorax 2004;59(Suppl II):S121.
36. Johns RH, Howell DCJ, Laurent GJ, et al. Absence of proteinase activated receptor-1 signalling affords protection from experimentally induced lung inflammation and fibrosis. Thorax 2004;59(Suppl II):T2.
37. Renzoni EA, Abraham DJ, Shi-Wen X, et al. Novel transforming growth factor beta transcriptional targets in adult lung fibroblasts identified by microarray analysis. Thorax 2004;59(Suppl II):S133.
38. Keating DK, Sadlier D, Hurson C, et al. Oligonucleotide microarray analysis reveals coordinated expression of extracellular matrix associated genes in pulmonary fibrosis in vitro. Thorax 2004;59(Suppl II):S134.
39. Watts K, Spiteri M. Simvastatin inhibits growth factor expression and modulates profibrotic markers in human lung fibroblasts. Thorax 2004;59(Suppl II):S132.
40. Story A, van Hest NAH, Goodburn A, et al. Targeted mobile digital chest radiography in the control of tuberculosis in high risk groups in London: a pilot project. Thorax 2004;59(Suppl II):P161.
41. Story A, Roberts W, Hayward AC. Tuberculosis in London: prevalence of disease and risk factors for poor adherence, drug resistance, and relapse. Thorax 2004;59(Suppl II):S115.
42. Craig GM, Booth H, Story A, et al. Preliminary findings from the London TB link project targeting homeless and marginalised groups. Thorax 2004;59(Suppl II):P159.
43. Antoine D, Crofts J, Story A, et al. Trends in anti-tuberculosis drugs resistance in England and Wales 1998-2001. Thorax 2004;59(Suppl II):S116.
44. Elkington PTG, O'Kane CM, Boyle JJ, et al. Mechanisms regulating matrix metalloproteinase gene expression and secretion in pulmonary tuberculosis. Thorax 2004;59(Suppl II):T5.
45. O'Kane CM, Elkington PTG, Friedland JS. Fibroblasts as a potent source of CXCL8 in tuberculosis. Thorax 2004;59(Suppl II):S10.
46. Dheda K, Huggett JF, Kim LU, et al. IL-4Δ2 and TH2 cytokines in human pulmonary tuberculosis. Thorax 2004;59(Suppl II):S11.
47. Derry DD, Possee RD, Griffin GE, et al. Discovery of proteins with role in defence against infection. Thorax 2004;59(Suppl II):S51.
48. Atkinson M, Lakhanpaul M, Smyth A, et al. PIVOT triol: a multicentre randomised equivalence trial to compare oral and IV treatment for community acquired pneumonia in children. Thorax 2004;59(Suppl II):S66.
49. Eastham KM, Parker L, Hammal D, et al. Community acquired pneumonia requiring admission to hospital is associated with chronic respiratory morbidity in childhood. Thorax 2004;59(Suppl II):S67.
50. Bertenshaw CJ, Watson AR, Choonara I, et al. The study of cystic fibrosis and acute renal failure (SCARF project): cose series. Thorax 2004;59(Suppl II):S33.
51. Al-Aloul M, Miller H, Ledson MJ, et al. Tobromycin nebuliser solution (TOBI): a renal sparing alternative to intravenous (IV) tobramycin in acute pulmonary exacerbations in CF. Thorax 2004;59(Suppl II):P120.
52. Mackerness KJ, Bush A, Jose PJ. Characterisation of neutrophil stimulating mediators in cystic fibrosis sputum. Thorax 2004;59(Suppl II):S53.
53. Hilliard TN, Shute J, Nicholson AG, et al. Transforming growth factor β1 and airway remodelling in children with cystic fibrosis. Thorax 2004;59(Suppl II):S79.
54. Welsh T, Green RH, Richardson D, et al. Tumour islet macrophages markedly improve survival in non small cell lung cancer. Thorax 2004;59(Suppl II):S71.
55. Ambalavanan S, Hanley SP, Weir DC, et al. The use of fuzzy logic based tumour markers for diagnosis of lung cancer. Thorax 2004;59(Suppl II):S75.
56. Mohan K, Smyth C, Ledson MJ, et al. Transbronchial needle aspiration in the UK: a national survey. Thorax 2004;59(Suppl II):S103.
57. Munavvar M, Singh H, Corless MJ, et al. Survey of the practice of interventional bronchoscopy in UK. Thorax 2004;59(Suppl II):P76.
58. Burrows NJ, Ali J, Cox GM. Medical thoracoscopy: a 5 year follow up survey of UK respiratory physicians. Thorax 2004;59(Suppl II):P135.
59. Slade MG, Pengelly GC. CuSum analysis to assess competence at transbronchial needle aspiration (TBNA): how many are enough? Thorax 2004;59(Suppl II):P77.
60. Crosbie PAJ, Bishop P, Haselton P, et al. Carcinoma in situ of the lung: an audit of incidence, treatment and outcome. Thorax 2004;59(Suppl II):P37.
61. Richardson CM, Anand A, Chaudhuri A, et al. What factors predict locol tumour recurrence following biopsy in malignant mesotheliomo? Thorax 2004;59(Suppl II):P41.
62. Smith N, Maguire J, Carr M, et al. Single Fraction radiotherapy to droin or thoracoscopy site as effective prophylaxis for tumour seeding in mesothelioma. Thorax 2004;59(Suppl II):P34.
63. Eraut D, Davison A, Ansari S, et al. Accelerated radical radiotherapy: an alternative to CHART. Thorax 2004;59(Suppl II):P35.
64. Wood M, Tuffin R, Spiro S, et al. What triggers referrals from primary to secondary care in possible lung cancer? Thorax 2004;59(Suppl II):P126.
65. Ladd B, Tuggey J, Bowker C, et al. A study to compare the efficiency of sterile talc, tetracycline, and bleomycin as sclerosing agents for medical pleurodesis in the treatment of malignant pleural effusions. Thorax 2004;59(Suppl II):S125.
66. Chakrabarti B, Ryland I, Sheard J, et al. The role of blind percutaneous pleural biopsy in the investigation of exudative pleural effusions. Tnorax 2004;59(Suppl II):S126.
67. Mallawathantri S, Lim WS, Kinnear W. Setting up a medical thoracoscopy service: safety and efficacy. Thorax 2004;59(Suppl II):S130.
68. Mackenzie Ross RV, Wade R, Pasteur MC. Complications of intercostal chest drains. Thorax 2004;59(Suppl II):S128.
69. Maskell NA, Davies CWH, Ghabe R, et al. Predictors of survival in patients with pleural infection but without cancer: results of the MRC/BTS MIST trial, ICTN 39138989. Thorax 2004;59(Suppl II):S127.
70. Walmsley SR, Print C, Johnson RS, et al. Hypoxia inhibits neutrophil apoptosis via hypoxia inducible factor (HIF)-1α-dependent regulation of NFκB. Thorax 2004;59(Suppl II):T4.
71. Perkins GD, McAuley DF, Gao F, et al. Intravenous salbutamol reduced alveolar-capillary permeability and extra-vascular lung water in ARDS: results of the BALTI study. Thorax 2004;59(Suppl II):T1.
72. Forrest IA, Murphy D, Lordan JL, et al. Epithelial to mesenchymal transition in clinically stable lung transplantation. Thorax 2004;59(Suppl II):T3.